Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
formulary
Pharma
Novo's Wegovy secures preferred obesity spot on CVS formulary
Novo has locked in a formulary deal with CVS that could give its star weight loss drug Wegovy a major advantage over its Eli Lilly rival Zepbound.
Fraiser Kansteiner
May 1, 2025 2:39pm
Indivior signs $600M deal to settle opioid marketing accusations
Jul 27, 2020 12:23pm
UnitedHealthcare backs Amgen biosims over Roche's oncology meds
Aug 16, 2019 10:55am
Novo’s oral semaglutide could disrupt diabetes coverage: analyst
Mar 5, 2019 12:05pm
CVS sidelines Amgen's Aimovig in favor of Teva, Lilly CGRP drugs
Jan 28, 2019 11:45am
Biogen, Teva benefit as payers ease up on MS meddling: analyst
Aug 30, 2018 12:25pm
